A Case of Mirtazapine-Induced Pancreatitis
- PMID: 37153315
- PMCID: PMC10159629
- DOI: 10.7759/cureus.37129
A Case of Mirtazapine-Induced Pancreatitis
Abstract
Acute pancreatitis is a concerning cause of hospitalization in the United States, with the most common etiologies being secondary to alcohol abuse and gallstones. Rarely, medications can trigger this inflammatory response, whether via direct toxic effects or other metabolic derangements. Mirtazapine is an antidepressant that has been associated with elevations in triglyceride levels on initiation. Relatedly, high triglyceride levels and autoimmune disorders are other causes of pancreatitis exacerbations. Here, we present the case of a female who was started on mirtazapine therapy and found to have elevated triglyceride levels. The course was complicated by acute pancreatitis requiring plasmapheresis, despite medication discontinuation, to which she responded well.
Keywords: acute pancreatitis; antidepressants; inflammation; mirtazapine; peri-pancreatic inflammation; plasmapheresis.
Copyright © 2023, Aslam et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- 
    - Drug induced pancreatitis. Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Best Pract Res Clin Gastroenterol. 2010;24:143–155. - PubMed
 
- 
    - Mirtazapine-induced acute pancreatitis in patients with depression: a systematic review. Milosavljević MN, Janković SM, Kostić MJ, Pejčić AV. J Psychiatr Pract. 2023;29:58–70. - PubMed
 
- 
    - American College of Gastroenterology guideline: management of acute pancreatitis. Tenner S, Baillie J, DeWitt J, Vege SS. Am J Gastroenterol. 2013;108:1400–1415. - PubMed
 
Publication types
LinkOut - more resources
- Full Text Sources
 
         
              